VitriVax

📍 Boulder, United States🗓 Founded 2017👥 23 employees💰 Last funded Dec 2022
Biotechnology Research🌐 vitrivaxbio.com
Website LinkedIn
VitriVax is a formulation technology company developing innovative solutions to maximize global accessibility and utility of human and animal vaccines. Our ALTA platform makes vaccines thermostable up to 70°C, and single shot - combining prime and boost doses into one injection.
1
Total investors
0
Early stage
1
Mid stage
0
Late stage
2017
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in VitriVax?
VitriVax has 1 investors on record on gritt.io, 1 mid-stage.
When did VitriVax last raise funding?
The most recent investment in VitriVax recorded on gritt.io was in December 2022.
When was VitriVax founded?
VitriVax was founded in 2017.
What industry is VitriVax in?
VitriVax operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is VitriVax based?
VitriVax is headquartered in Boulder, United States.